BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 11913222)

  • 1. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
    Bäck M
    Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinyl leukotriene receptor assays.
    Muccitelli RM; Luttmann MA; Hay DW
    Curr Protoc Pharmacol; 2001 May; Chapter 4():Unit 4.16. PubMed ID: 22293965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M
    Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
    Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
    Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
    Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
    Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
    Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene-induced contraction is mediated by cysteinyl leukotriene receptor CysLT1 in guinea pig fundus but by CysLT1 and CysLT2 in antrum.
    Huang SC
    Life Sci; 2011 Apr; 88(17-18):819-24. PubMed ID: 21396378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism.
    Pedersen KE; Bochner BS; Undem BJ
    J Pharmacol Exp Ther; 1997 May; 281(2):655-62. PubMed ID: 9152370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
    Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
    Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma.
    Sakata K; Bäck M
    Eur J Pharmacol; 2002 Feb; 436(1-2):119-26. PubMed ID: 11834255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl leukotriene receptors.
    Evans JF
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():587-97. PubMed ID: 12432945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum.
    Bäck M; Jonsson EW; Dahlén SE
    Eur J Pharmacol; 1996 Dec; 317(1):107-13. PubMed ID: 8982726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional studies of leukotriene receptors in vascular tissues.
    Walch L; Norel X; Gascard JP; Brink C
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S107-11. PubMed ID: 10673237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
    Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of receptors for cysteinyl-leukotrienes in sheep trachealis muscle.
    Jonsson EW
    Pulm Pharmacol Ther; 1997; 10(1):29-36. PubMed ID: 9344830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes.
    Bäck M; Norel X; Walch L; Gascard J; Mazmanian G; Dahlén S; Brink C
    Eur J Pharmacol; 2000 Aug; 401(3):381-8. PubMed ID: 10936497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl-leukotriene receptors in pulmonary vessels.
    Walch L; Norel X; Gascard JP; Brink C
    J Physiol Pharmacol; 1999 Dec; 50(4):567-73. PubMed ID: 10639007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural and myogenic effects of leukotrienes C4, D4, and E4 on canine bronchial smooth muscle.
    Abela A; Daniel EE
    Am J Physiol; 1994 Apr; 266(4 Pt 1):L414-25. PubMed ID: 8179018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.